Thus, residue Phe-431 of BCRP is important for the pharmacological interaction with sunitinib and FTC.
This is the first report showing a differential effect of a germ-line variation of the BCRP/ABCG2 gene on the pharmacological interaction between small-molecule TKIs and BCRP.